HIV/AIDS in Vancouver, British Columbia: a growing epidemic CW McInnes, E Druyts, SS Harvard, M Gilbert, MW Tyndall, VD Lima, ... Harm Reduction Journal 6, 1-5, 2009 | 70 | 2009 |
Agreement between aggregate and individual-level measures of income and education: a comparison across three patient groups CA Marra, LD Lynd, SS Harvard, M Grubisic BMC health services research 11, 1-7, 2011 | 49 | 2011 |
Consumer preferences for food allergen labeling CA Marra, S Harvard, M Grubisic, J Galo, A Clarke, S Elliott, LD Lynd Allergy, Asthma & Clinical Immunology 13, 1-11, 2017 | 38 | 2017 |
Social, ethical, and other value judgments in health economics modelling S Harvard, GR Werker, DS Silva Social Science & Medicine 253, 112975, 2020 | 34 | 2020 |
Randomized controlled trial evaluating pictogram augmentation of HIV medication information K Wilby, CA Marra, JH da Silva, M Grubisic, S Harvard, LD Lynd Annals of Pharmacotherapy 45 (11), 1378-1383, 2011 | 33 | 2011 |
Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia C Panessa, WD Hill, E Giles, A Yu, S Harvard, G Butt, A Andonov, ... Journal of Viral Hepatitis 16 (1), 64-73, 2009 | 32 | 2009 |
Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation-an economic analysis based on the ESPOIR cohort K Chevreul, G Haour, S Lucier, S Harvard, ML Laroche, X Mariette, ... PLoS One 9 (5), e97077, 2014 | 28 | 2014 |
Value judgments in a COVID-19 vaccination model: a case study in the need for public involvement in health-oriented modelling S Harvard, E Winsberg, J Symons, A Adibi Social Science & Medicine 286, 114323, 2021 | 25 | 2021 |
Mortality is influenced by locality in a major HIV/AIDS epidemic EF Druyts, BS Rachlis, VD Lima, SS Harvard, W Zhang, EK Brandson, ... HIV medicine 10 (5), 274-281, 2009 | 24 | 2009 |
Ontario’s plunging price-caps on generics: deeper dives may drown some drugs A Anis, S Harvard, C Marra Open Medicine 5 (3), e149, 2011 | 22 | 2011 |
Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort S Harvard, D Guh, N Bansback, P Richette, M Dougados, A Anis, ... RMD open 2 (1), e000230, 2016 | 21 | 2016 |
The epistemic risk in representation S Harvard, E Winsberg Kennedy Institute of Ethics Journal 32 (1), 1-31, 2022 | 18 | 2022 |
Purposes and duties in scientific modelling E Winsberg, S Harvard J Epidemiol Community Health 76 (5), 512-517, 2022 | 16 | 2022 |
More than just needles: An evidence-informed approach to enhancing harm reduction supply distribution in British Columbia JA Buxton, EC Preston, S Mak, S Harvard, J Barley, ... Harm Reduction Journal 5, 1-7, 2008 | 14 | 2008 |
Canadian policy on food allergen labelling: consumers’ perspectives regarding unment needs KM Brown, NE Fenton, LD Lynd, CA Marra, JM FitzGerald, SS Harvard, ... Univers J Public Health 3, 41-48, 2015 | 13 | 2015 |
Health economists on involving patients in modeling: potential benefits, harms, and variables of interest S Harvard, GR Werker Pharmacoeconomics 39, 823-833, 2021 | 12 | 2021 |
Harm reduction product distribution in British Columbia SS Harvard, WD Hill, JA Buxton Canadian journal of public health 99, 446-450, 2008 | 12 | 2008 |
Measurable definitions of ankylosing spondylitis management recommendations are needed for use in observational studies S Harvard, L Gossec, T Pham, P Richette, M Dougados, A Anis, B Fautrel Joint bone spine 83 (1), 101-103, 2016 | 10 | 2016 |
Generalizability of risk stratification algorithms for exacerbations in COPD JK Ho, A Safari, A Adibi, DD Sin, K Johnson, M Sadatsafavi, N Bansback, ... Chest 163 (4), 790-798, 2023 | 8 | 2023 |
Causal inference, moral intuition, and modeling in a pandemic S Harvard, E Winsberg Philosophy of Medicine 2 (2), 2021 | 8 | 2021 |